Tag: Eli Lilly

Pharmaceutical giant Eli Lilly finds itself navigating a complex pricing landscape as new regulatory measures from the Trump administration compel ...

Eli Lilly stands poised to revolutionize obesity treatment with its experimental oral medication Orforglipron, following outstanding Phase 3 clinical trial ...

Pharmaceutical leader Eli Lilly is positioned to significantly disrupt the GLP-1 drug sector with its innovative oral diabetes treatment, orforglipron. ...

Investors are watching Eli Lilly and Company closely as the pharmaceutical giant's shares continue to trade heavily but lack decisive ...

Pharmaceutical giant Eli Lilly & Co. has delivered a trifecta of positive developments: exceptional quarterly earnings, a major expansion initiative ...

A surprising executive departure at pharmaceutical giant Eli Lilly has unsettled investors. Anne White, President of the highly profitable Neuroscience ...

Pharmaceutical giant Eli Lilly and Company is navigating a significant executive transition that has unsettled investors. Anne White, a 30-year ...

Eli Lilly & Company's leadership has made a substantial vote of confidence in the pharmaceutical giant's future. Chairman David Ricks ...

Pharmaceutical giant Eli Lilly is facing its worst stock market performance in 25 years, with shares plummeting 14% in a ...

Eli Lilly is poised to capitalize on explosive growth in India for its diabetes and weight-loss drug Mounjaro, with sales ...